HLA-DRA Recombinant Monoclonal Antibody
The HLA-DRA Recombinant Monoclonal Antibody is applicable for the following applications: ELISA, WB. Host: Rabbit. Species Reactivity: Human (Homo sapiens) . Immunogen: A synthesized peptide derived from human HLA-DRA. Accession Number: P01903. Target Synonyms: HLA class II histocompatibility antigen; DR alpha chain (MHC class II antigen DRA) ; HLA-DRA; HLA-DRA1. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
Short Description
The HLA-DRA Recombinant Monoclonal Antibody is applicable for the following applications: ELISA, WB
Accession Number
P01903
Host
Rabbit
Reactivity
Human (Homo sapiens)
Immunogen
A synthesized peptide derived from human HLA-DRA
Target
HLA-DRA
Clonality
Recombinant Monoclonal
Clone
6C11
Conjugation
Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.
Applications
ELISA, WB
Field of Research
Others
Purification
Affinity chromatography
Concentration
Lot specific. Please inquire or refer to the datasheet included in the product pouch.
Format
Liquid
Buffer
PBS, 150mM NaCl, 50% Glycerol, 0.05% BSA, 0.02% Sodium Azide, pH 7.4
Shipping Conditions
Ice packs
Storage Conditions
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Fragment
IgG
Target Alternative Name
HLA class II histocompatibility antigen; DR alpha chain (MHC class II antigen DRA) ; HLA-DRA; HLA-DRA1
Species
Human (Homo sapiens)
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LILRA3 (ILT6, CD85e, Leukocyte Immunoglobulin-like Receptor Subfamily A Member 3, CD85 Antigen-like Family Member E, Immunoglobulin-like Transcript 6, ILT-6, Leukocyte Immunoglobulin-like Receptor 4, LIR-4, Monocyte Inhibitory Receptor HM43/HM31, LIR4)
CEBPE (CCAAT/Enhancer-binding Protein epsilon, C/EBP epsilon) (MaxLight 490)